ArticleJournal of acquired immune deficiency syndromes (1999)2026
Brief Report: Is Gestational Exposure to HIV and Protease Inhibitors Associated With Timing of Pubertal Onset?
Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundFew studies have evaluated the influence of gestational HIV/antiretroviral exposure on pubertal onset in children who are HIV-exposed but uninfected (CHEU).
methodsCHEU in the Surveillance Monitoring for ART Toxicities study and children HIV-unexposed uninfected (CHUU) in the Bone Mineral Density in Childhood Study with Tanner staging at age 9 years were included. Pubertal onset was defined as Tanner stage ≥2 for each sex-specific puberty indicator. Log-binomial regression models were fit to estimate relative risks (RRs) of pubertal onset in CHEU vs. CHUU, adjusted for exact age and other covariates. Among CHEU, models were fit to assess the association of pubertal onset with maternal protease inhibitor exposure, CD4 count, and earliest HIV viral load (VL) during pregnancy.
resultsIn total, 227 CHEU (114 female, 113 male) and 344 CHUU (182 female, 162 male) were included. Among male CHEU, the adjusted likelihood of pubertal onset by age 9 years was 2.07 times higher [95% CI: 0.89 to 4.79] for genitalia and 3.55 times higher [95% CI: 0.92 to 13.81] for pubic hair than male CHUU. Pubertal onset was similar in female CHEU and CHUU. Among male CHEU, a maternal VL ≥400 copies/mL was associated with a greater likelihood of pubertal onset (adjusted RR: 12.6 [95% CI: 1.56 to 102] for genitalia and 9.85 [95% CI: 1.17 to 83] for pubic hair).
conclusionsGestational HIV exposure and exposure to higher maternal HIV viral load were associated with greater likelihood of pubertal onset by age 9 years in male CHEU. Further confirmatory and mechanistic studies are warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.